Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RALF trial of aliskiren for prevention of atrial fibrillation in pacemaker patients
2009-016077-14Phase 4Terminated
- Sponsor
- Mika Lehto
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of aliskiren in Atrial fibrillation (AFib) (2 arms), sponsored by Mika Lehto. Primary endpoint: Atrial fibrillation burden excluding episodes longer than 48 hours. Started Jun 2010; status: terminated.
02
Drugs
aliskiren
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2009-016077-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016077-14.